Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2015
At a glance
- Drugs Alemtuzumab (Primary) ; Alemtuzumab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 14 Dec 2015 New trial record